DBV Technologies (DBVT) EBIT Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -80.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.08% |
| Dec 31, 2025 | -88.81% |
| Sep 30, 2025 | -13.02% |
| Jun 30, 2025 | -21.48% |
| Mar 31, 2025 | 6.86% |
| Dec 31, 2024 | -100.18% |
| Sep 30, 2024 | -66.00% |
| Jun 30, 2024 | -34.96% |
| Mar 31, 2024 | -34.93% |
| Dec 31, 2023 | 68.65% |
| Sep 30, 2023 | -1.39% |
| Jun 30, 2023 | -5.26% |
| Mar 31, 2023 | -26.20% |
| Dec 31, 2022 | -182.09% |
| Sep 30, 2022 | 26.05% |
| Jun 30, 2022 | 23.48% |
| Mar 31, 2022 | 43.41% |
| Dec 31, 2021 | 66.44% |
| Sep 30, 2021 | 18.13% |
| Jun 30, 2021 | 34.72% |
| Mar 31, 2021 | 28.11% |
| Sep 30, 2020 | 77.31% |
| Sep 30, 2019 | -156.52% |
| Jun 30, 2016 | -238.41% |
| Dec 31, 2015 | -8.30% |
| Jun 30, 2015 | 0.50% |